Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer

Clinical trial NCT07412613 · RECRUITING

Trial details

NCT number: NCT07412613
Sponsor: Akeso
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Resectable Colon Cancer MSI-H/dMMR Colorectal Cancer

Start date: 2026-04-15
Primary completion: 2030-06-15
Enrollment: 386

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.